《盈警響號》棠記控股(08305.HK)料去年盈轉虧 蝕不少於50萬元
棠記控股(08305.HK)公布,與2019年之綜合盈利220萬元相比,集團預期於截至去年12月31日止年度將錄得綜合虧損不少於50萬元。合盈利下跌主要由於毛利嚴重下降,由於生產成本增加;銷售減少;及行政開支增加,主要由於去年的預期信貸虧損撥備增加及折舊增加踏入去年,新型冠狀病毒的爆發及其後全球疫情加劇,在商業營運及經濟方面造成前所未有的干擾。
集團指,隨著形勢不斷變化,很難估計此類事件的長遠影響,但集團一直積極密切留意市場狀況並採取適當措施應對挑戰。去年集團受疫情影響,於2月至8月的部份建築工程已被暫時中止,導致集團正在進行的項目進度延誤,而去年確認的工作量有所減少。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.